We are live on ! Find out more
DA

Dunvegan Associates Portfolio holdings

AUM $85.1M
1-Year Est. Return 2.3%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
-2.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$2.39M
Cap. Flow
-$3.06M
Cap. Flow %
-2.58%
Top 10 Hldgs %
49.96%
Holding
224
New
153
Increased
5
Reduced
49
Closed
8

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.01M
2
LNG icon
Cheniere Energy
LNG
+$918K
3
V icon
Visa
V
+$252K
4
CBI
Chicago Bridge & Iron Nv
CBI
+$172K
5
AAPL icon
Apple
AAPL
+$149K

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$3.83M
2
GLD icon
SPDR Gold Trust
GLD
+$1.84M
3
NVO
Novo Nordisk
NVO
+$1.27M
4
GEB.CL
General Electric Capital Corp
GEB.CL
+$1.05M
5
SCHW.PRB.CL
The Charles Schwab Corporation
SCHW.PRB.CL
+$755K

Sector Composition

Rank Sector Weight
1 Energy 20.26%
2 Financials 13.68%
3 Healthcare 11.87%
4 Consumer Staples 10.96%
5 Materials 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
176
Philip Morris
PM
$297B
$8K 0.01%
+100
New +$8.08K
TGT icon
177
Target
TGT
$65.6B
$8K 0.01%
+140
New +$8.3K
ESRX
178
DELISTED
Express Scripts Holding Company
ESRX
$8K 0.01%
+110
New +$8.24K
EMC
179
DELISTED
EMC CORPORATION
EMC
$8K 0.01%
+290
New +$7.54K
FISV
180
Fiserv Inc
FISV
$28.8B
$7K 0.01%
+240
New +$6.87K
TPR icon
181
Tapestry
TPR
$30.8B
$7K 0.01%
+150
New +$7.47K
HSP
182
DELISTED
HOSPIRA INC
HSP
$7K 0.01%
+170
New +$7.29K
CAT icon
183
Caterpillar
CAT
$375B
$6K 0.01%
+60
New +$5.66K
CMCSA icon
184
Comcast
CMCSA
$85B
$6K 0.01%
+240
New +$6.25K
CNI icon
185
Canadian National Railway
CNI
$76.9B
$6K 0.01%
+110
New +$6.06K
HOLX
186
DELISTED
Hologic
HOLX
$6K 0.01%
+300
New +$6.47K
XLB icon
187
State Street Materials Select Sector SPDR ETF
XLB
$8.36B
$6K 0.01%
+240
New +$5.52K
DNR
188
DELISTED
Denbury Resources, Inc.
DNR
$6K 0.01%
+380
New +$6.17K
SYNM
189
DELISTED
SYNTROLEUM CORP COM STK NEW (DE)
SYNM
$6K 0.01%
+1,460
New +$5.34K
AMGN icon
190
Amgen
AMGN
$208B
$5K ﹤0.01%
+40
New +$4.85K
DVN icon
191
Devon Energy
DVN
$52.1B
$5K ﹤0.01%
+70
New +$4.34K
EW icon
192
Edwards Lifesciences
EW
$49.6B
$5K ﹤0.01%
+420
New +$4.85K
LUMN icon
193
Lumen
LUMN
$6.57B
$5K ﹤0.01%
+147
New +$4.5K
NEM icon
194
Newmont
NEM
$98.7B
$4K ﹤0.01%
+160
New +$3.81K
ROP icon
195
Roper Technologies
ROP
$38.8B
$4K ﹤0.01%
+30
New +$4.08K
TRAW icon
196
Traws Pharma
TRAW
$6.85M
– –
0
– –
LBTYA icon
197
Liberty Global Class A
LBTYA
$3.62B
$3K ﹤0.01%
+82
New +$2.88K
TCS
198
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$3K ﹤0.01%
+7
New +$3.85K
POT
199
DELISTED
Potash Corp Of Saskatchewan
POT
$3K ﹤0.01%
+77
New +$2.59K
C icon
200
Citigroup
C
$222B
$2K ﹤0.01%
+50
New +$2.49K
5 6 7
8
9

Similar funds

TSBJ
Trevor, Stewart, Burton & Jacobsen New York $88.4M AUM 7.43% 1-Year Est. Return
VCAM
Valentine Capital Asset Management Danville, California $89.6M AUM 0.84% 1-Year Est. Return
KCA
KR Capital Advisors New York $80M AUM 4.21% 1-Year Est. Return
TP
TB Partners Shanghai, China $90.9M AUM
SPC
Standard Pacific Capital San Francisco, California $92M AUM 5.65% 1-Year Est. Return
ST
Semper Trust King Of Prussia, Pennsylvania $71.9M AUM
CGC
Cloud Gate Capital Chicago, Illinois $70.7M AUM 11.83% 1-Year Est. Return
GCG
Giovine Capital Group Santa Monica, California $68.7M AUM 2.56% 1-Year Est. Return

Dunvegan Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Dunvegan Associates held 224 positions worth $119M, down 2% from $121M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Dunvegan Associates's Q1 2014 filing shows 153 new, 5 increased, 49 reduced and 8 closed positions. Its largest new stake was Allergan plc: 30,358 shares worth $3.77M. The largest sale was Allergan Inc, an estimated $3.83M.

By sector, the portfolio is most concentrated in Energy at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Dunvegan Associates's largest Q1 2014 buy was Allergan plc: 30,358 shares worth $3.77M.
  • Dunvegan Associates added most to Cheniere Energy in Q1 2014, an estimated $918K increase.
  • Dunvegan Associates's biggest Q1 2014 reduction was SPDR Gold Trust, cutting an estimated $1.84M.
  • Dunvegan Associates fully exited Allergan Inc in Q1 2014, selling an estimated $3.83M.
  • Dunvegan Associates's ten largest holdings make up 50% of its $119M portfolio in Q1 2014.
  • Dunvegan Associates opened 153 new positions and closed 8 in Q1 2014.
  • Dunvegan Associates's portfolio value fell 2% quarter-over-quarter to $119M.

Based on Dunvegan Associates's 13F filing for Q1 2014, filed 28 Apr 2017.